Science Explorer Back to mapMap
Discussion
Company · Pilsen · Czechia

Biopticka Laborator (Czechia)

World rank, all time
#31,549
of 34,923
Rank in Czechia
#159
of 198
Research works
144
▲ 49% vs 2018-21
Citations
2k
14.0 per fractional work
Top-10% rate
20.5%
all institutions 10.0%
vs its own fields
1.11×
1.00× is exactly expected
Open access
37%
world 40%
International
51%
world 18%

Which fields of science does Biopticka Laborator (Czechia) work in?

In 2022-now, 81% of research at Biopticka Laborator (Czechia) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (79%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (3%). It does 3.0× the world's share of Health Sciences.

Health Sciences: 44 fractional works · 81.3% of its workMedicine: 42 fractional works · 78.9% of its workSurgery: 7 fractional works · 13.8% of its workPulmonary and Respiratory Medicine: 7 fractional works · 12.8% of its workOncology: 5 fractional works · 9.6% of its workPathology and Forensic Medicine: 3 fractional works · 6.5% of its workRheumatology: 3 fractional works · 6.1% of its workNeurology: 2 fractional works · 3.9% of its workObstetrics and Gynecology: 2 fractional works · 3.9% of its workEpidemiology: 2 fractional works · 3.6% of its workReproductive Medicine: 2 fractional works · 2.9% of its workGenetics: 2 fractional works · 2.8% of its workPhysiology: 1 fractional works · 2.7% of its workDermatology: 1 fractional works · 2.6% of its workOtorhinolaryngology: 1 fractional works · 1.2% of its workInfectious Diseases: 1 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workMicrobiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workDentistry: 1 fractional works · 1.8% of its workOral Surgery: 1 fractional works · 1.4% of its workPeriodontics: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.3% of its workSpeech and Hearing: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 10 fractional works · 18.4% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 13.8% of its workMolecular Biology: 5 fractional works · 8.9% of its workCancer Research: 1 fractional works · 2.1% of its workGenetics: 1 fractional works · 2.1% of its workCell Biology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 2 fractional works · 3.4% of its workImmunology: 1 fractional works · 2.0% of its workParasitology: 0 fractional works · 0.9% of its workMicrobiology: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.6% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workInsect Science: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.2% of its workCultural Studies: 0 fractional works · 0.2% of its workPhysical Sciences: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.1% of its workALL ITS WORKBioptickaLaborator…54fractional works, 2022-now
Life Sciences18%Physical Sciences0%Health Sciences81%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine4278.9%
    2. Dentistry11.8%
    3. Health Professions00.3%
    4. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology713.8%
    2. Immunology and Microbiology23.4%
    3. Neuroscience00.6%
    4. Agricultural and Biological Sciences00.5%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Social Sciences00.2%
    1. Computer Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.60× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 3.33× its world share, 2 worksImmunology and Micro…Neuroscience: 0.37× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.35× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.01× its world share, 0 worksComputer ScienceDentistry: 3.79× its world share, 1 worksDentistryHealth Professions: 0.12× its world share, 0 worksHealth ProfessionsMedicine: 4.11× its world share, 42 worksMedicineVeterinary: 1.52× its world share, 0 worksVeterinarySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Medicine4.11×42 works
  2. Dentistry3.79×1 works
  3. Immunology and Microbiology3.33×2 works
  4. Biochemistry, Genetics and Molecular Biology2.60×7 works
  5. Veterinary1.52×0 works
  6. Neuroscience0.37×0 works
  7. Pharmacology, Toxicology and Pharmaceutics0.35×0 works
  8. Health Professions0.12×0 works
  9. Agricultural and Biological Sciences0.11×0 works
  10. Social Sciences0.02×0 works
  11. Computer Science0.01×0 works

Who are the top researchers at Biopticka Laborator (Czechia)?

Ranked on the quality score, Veronika Hájková, Monika Šedivcová and Martina Putzová lead among researchers whose main affiliation is Biopticka Laborator (Czechia).

  1. 1 Veronika Hájková Czechia · #1,523,709 worldwide 561 citations · 51 works
  2. 2 Monika Šedivcová Czechia · #2,322,654 worldwide 695 citations · 28 works
  3. 3 Martina Putzová Czechia · #4,961,846 worldwide 236 citations · 31 works
  4. 4 Z Kinkor Czechia · #5,094,656 worldwide 206 citations · 40 works
  5. 5 Kateřina Černá Czechia · #5,199,343 worldwide 136 citations · 25 works
All ranked researchers at Biopticka Laborator (Czechia)

What are the most cited papers from Biopticka Laborator (Czechia)?

The most cited paper from Biopticka Laborator (Czechia) is "Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity" (Alena Skálová, Tomáš Vaněček, Radek Šíma et al., 2010), with 1,032 citations. Next come "Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands" (387) and "The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas" (227).

Most cited papers
#PaperReleasedCitations
1 Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity Alena Skálová, Tomáš Vaněček, Radek Šíma et al. · The American Journal of Surgical Pathology 20 Apr 2010 1,032
2 Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands Alena Skálová, Martin D. Hyrcza, Ilmo V.V. Leivo · Head and Neck Pathology Open access Mar 2022 387
3 The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas Alena Skálová, Göran Stenman, Roderick H.W. Simpson et al. · The American Journal of Surgical Pathology 27 Oct 2017 227
4 Mammary Analogue Secretory Carcinoma of Salivary Glands With High-grade Transformation Alena Skálová, Tomáš Vaněček, Hanna Majewska et al. · The American Journal of Surgical Pathology 21 Oct 2013 210
5 Mammary Analogue Secretory Carcinoma of Salivary Glands Alena Skálová, Tomáš Vaněček, Roderick H.W. Simpson et al. · The American Journal of Surgical Pathology 22 Oct 2015 193
All 60 most cited papers, with filters and sorting

Which keywords describe research at Biopticka Laborator (Czechia)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Prognostic Factors, Chemotherapy, Molecular Classification, Clinical Practice Guidelines, Immunotherapy, Radiotherapy, Genetic Mutations and Osteosarcoma.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors10▲ 43×10 topics
  2. Chemotherapy8▲ 21×14 topics
  3. Molecular Classification6▲ 69×4 topics
  4. Clinical Practice Guidelines5▲ 18×5 topics
  5. Immunotherapy5▲ 13×12 topics
  6. Radiotherapy5▲ 24×6 topics
  7. Epidemiology5▲ 2.2×25 topics
  8. Genetic Mutations4▲ 18×9 topics
  9. Osteosarcoma4▲ 156×1 topic
  10. Soft Tissue Sarcoma4▲ 137×1 topic
  11. Adenoid Cystic Carcinoma3▲ 247×1 topic
  12. Salivary Gland Tumors3▲ 247×1 topic
  13. Radiation Therapy3▲ 41×6 topics
  14. Metastasis3▲ 14×6 topics
  15. Treatment3▲ 4.0×10 topics
  16. Cancer2▲ 3.4×14 topics
  17. Molecular Characterization2▲ 25×4 topics
  18. Chemoradiotherapy2▲ 78×2 topics
  19. Clinical Trials2▲ 6.2×4 topics
  20. Therapy2▲ 21×3 topics
  21. Biomarkers2▲ 5.7×5 topics
  22. Genomic Analysis2▲ 15×2 topics
  23. Surgical Management2▲ 9.5×6 topics
  24. Cervical Cancer2▲ 35×2 topics
  25. Immunohistochemistry2▲ 53×4 topics
  26. Granular Cell Tumor2▲ 206×1 topic
  27. Immunohistochemical Assessment2▲ 206×1 topic
  28. Prognosis2▲ 9.7×4 topics
  29. Surgery2▲ 9.2×3 topics
  30. Cytoreductive Surgery2▲ 47×2 topics
  31. Squamous Cell Carcinoma2▲ 33×2 topics
  32. Survival Analysis2▲ 11×4 topics
  33. Desmoid Tumor2▲ 197×1 topic
  34. Solitary Fibrous Tumor2▲ 197×1 topic
  35. Targeted Therapy2▲ 13×5 topics
  36. Tumor Suppressor2▲ 71×2 topics
  37. Clinical Management1▲ 16×4 topics
  38. Glioblastoma1▲ 39×1 topic
  39. Human Papillomavirus1▲ 22×3 topics
  40. Temozolomide1▲ 39×1 topic

Which research topics does Biopticka Laborator (Czechia) publish most on?

By volume in 2022-now: Sarcoma Diagnosis and Treatment, Salivary Gland Tumors Diagnosis and Treatment, Tumors and Oncological Cases and Soft tissue tumor case studies.

  1. 1 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
  2. 2 Salivary Gland Tumors Diagnosis and Treatment Surgery 3 works
  3. 3 Tumors and Oncological Cases Pathology and Forensic Medicine 2 works
  4. 4 Soft tissue tumor case studies Rheumatology 2 works
  5. 5 Glioma Diagnosis and Treatment Genetics 1 works
  6. 6 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
  7. 7 Cancer and Skin Lesions Dermatology 1 works
  8. 8 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
  9. 9 Neuroblastoma Research and Treatments Neurology 1 works
  10. 10 Ear and Head Tumors Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.3%not open62.7%

World: 40% of research is openly available.

with international co-authors51.0%domestic only49.0%

World: 18% is written across borders.

How has Biopticka Laborator (Czechia)'s research output changed?

Output in 2022-2025 was 49% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biopticka Laborator (Czechia) as a percentage of every work published that year, 0.00021% in 2024.

still counting0.00010%0.00020%0.00030%Biopticka Laborator (Czechia)0.00027% in 2025200020102020

Fractional works of Biopticka Laborator (Czechia) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Pilsen

All research institutions in Pilsen

Share Biopticka Laborator (Czechia)'s ranking

Biopticka Laborator (Czechia) on Science Explorer

A card with Biopticka Laborator (Czechia)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biopticka Laborator (Czechia). Posts are plain text and can be reported.